Etiology of Polycystic Kidney Disease
Polycystic kidney disease is caused by pathogenic genetic mutations, with autosomal dominant polycystic kidney disease (ADPKD) resulting primarily from mutations in PKD1 (approximately 48% truncating, 19% non-truncating variants) or PKD2 (approximately 15% of cases), which encode polycystin-1 and polycystin-2 proteins respectively 1.
Major Genetic Causes
PKD1 and PKD2 Genes (>90% of diagnosed families)
The two major genes account for the vast majority of ADPKD cases 1:
PKD1 mutations (~67% combined): Encode polycystin-1, a large receptor-like protein
- Truncating variants (~48%): Result in complete loss of protein function, typically causing severe disease with kidney failure in the 50s
- Non-truncating variants (~19%): Variable phenotype ranging from severe to mild depending on residual protein function
PKD2 mutations (~15%): Encode polycystin-2, a transient receptor potential channel protein
Minor ADPKD Genes (<10% of cases)
Several minor genes with definitive-to-moderate evidence include 1:
- IFT140 (1-2%): Associated with few large bilateral cysts, kidney function usually preserved into old age
- DNAJB11 (<0.5%): Progressive CKD but kidney failure typically in the 70s
- GANAB (<0.5%): Mild PKD with limited CKD progression
- ALG5, ALG9 (<0.5% each): Low-to-moderate cyst numbers
- NEK8 (<0.5%): Can cause kidney failure in childhood; 75% are de novo occurrences
Pathophysiological Mechanism
The genetic mutations disrupt normal cellular processes 4, 3:
- Primary cilium dysfunction: The polycystin complex acts as a mechanosensor in primary cilia, essential for maintaining differentiated epithelial state
- Calcium signaling defects: Reduction of intracellular calcium ions
- Increased cAMP: Promotes cyst enlargement through transepithelial fluid secretion and cell proliferation
- Abnormal pathway activation: MAPK/ERK, mTOR, JAK/STAT, and other signaling pathways become dysregulated
- Metabolic alterations: Defective glucose metabolism, impaired beta-oxidation, and abnormal mitochondrial activity
Inheritance Pattern and Prevalence
ADPKD follows an autosomal dominant inheritance pattern, meaning a single mutated copy from one parent causes disease 1, 2. The estimated prevalence is 1 per 1,000 in the general population, making it the most common inherited kidney disease 2, 4. However, diagnosed prevalence in databases is lower (2-4 per 10,000), suggesting many cases remain undiagnosed 1.
Unusual Genetic Constellations
Very-early-onset or rapidly progressive disease may result from 5:
- Biallelic mutations: Homozygous, compound heterozygous, or digenic mutations with at least one hypomorphic allele
- Contiguous gene deletion syndromes: Such as PKD1-TSC2 deletions that radically alter phenotype
- Mimicking conditions: HNF1B mutations can mimic ADPKD with different prognostic implications
Clinical Caveat
Approximately 10% of cases remain genetically unresolved despite testing 1. In children with very-early-onset disease or negative family history with progressive disease, multigene panel testing is recommended rather than single-gene testing due to phenotypic overlap with other cystic kidney diseases 5.